A growing body of evidence suggests marijuana may greatly benefit Alzheimer’s patients.
New research published in The Journal of Alzheimer’s Disease finds that administering cannabis extracts containing THC to Alzheimer’s patients helped relieve various symptoms of dementia, including agitation, aggression, apathy and delusions.
The small trial conducted by Israeli researchers studied 11 Alzheimer’s patients who were given medical cannabis oil containing THC over the course of four weeks. Of the 10 patients that completed the trial, researchers recorded “significant reduction” in behavioral and psychological symptoms of dementia.
Researchers concluded that “adding medical cannabis oil to Alzheimer’s disease patients’ pharmacotherapy is a safe and promising treatment option.”
This is just the latest in a line of studies to indicate THC relieves dementia symptoms and may also act as an Alzheimer’s inhibitor.
Alzheimer’s disease is believed to be caused by long-term brain inflammation and cannabis acts as a powerful anti-inflammatory, as reported by SFGate.
Smoking, vaping, or eating the pot molecules THC and CBD directly effects nerve cell function, reducing chronic brain inflammation, oxidative stress, and cellular dysfunction — all the while promoting stability of the human body’s internal environment (homeostasis) and healthy brain cells (neurotrophic support), studies show.
TIME reported in 2012 that cannabis use appears to slow brain aging.